CVS HEALTH Corp Stockholders Equity

• CVS HEALTH Corp showed a decrease of -0.5% in Stockholders Equity from 2024 to 2025.
• This data is from CVS HEALTH Corp's annual report (Form 10-K), filed with the SEC on February 10, 2026.
• XBRL data for this metric is available from 2007 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: $36.15 billion | Q3 2009: $35.67 billion | Q1 2010: $35.69 billion | Q2 2010: $35.87 billion | Q3 2010: $36.64 billion | Q4 2010: $37.70 billion | Q1 2011: $37.92 billion | Q2 2011: $38.24 billion | Q3 2011: $37.49 billion | Q1 2014: $38.21 billion | Q2 2014: $38.13 billion | Q3 2014: $38.10 billion | Q1 2015: $36.99 billion | Q2 2015: $37.13 billion | Q3 2015: $37.17 billion | Q1 2016: $36.03 billion | Q2 2016: $34.76 billion | Q3 2016: $35.95 billion | Q1 2017: $33.84 billion | Q2 2017: $34.14 billion | Q3 2017: $34.86 billion | Q1 2018: $38.67 billion | Q2 2018: $35.61 billion | Q3 2018: $36.62 billion | Q1 2019: $59.69 billion | Q2 2019: $61.28 billion | Q3 2019: $62.61 billion | Q1 2020: $65.14 billion | Q2 2020: $68.02 billion | Q3 2020: $68.81 billion | Q1 2021: $70.85 billion | Q2 2021: $73.24 billion | Q3 2021: $74.31 billion | Q1 2022: $73.83 billion | Q2 2022: $75.18 billion | Q3 2022: $70.68 billion | Q1 2023: $71.38 billion | Q2 2023: $72.73 billion | Q3 2023: $74.34 billion | Q1 2024: $73.97 billion | Q2 2024: $74.93 billion | Q3 2024: $74.94 billion | Q1 2025: $76.93 billion | Q2 2025: $77.38 billion | Q3 2025: $72.93 billion.
• Over the full 18 years of available data (2007 to 2025), CVS HEALTH Corp's Stockholders Equity has grown by 140.1%.
• Historical annual values: Fiscal year 2025: $75.21 billion | Fiscal year 2024: $75.56 billion | Fiscal year 2023: $76.46 billion | Fiscal year 2022: $71.47 billion | Fiscal year 2021: $75.08 billion | Fiscal year 2020: $69.39 billion | Fiscal year 2019: $63.86 billion | Fiscal year 2018: $58.23 billion | Fiscal year 2017: $37.69 billion | Fiscal year 2016: $36.83 billion | Fiscal year 2015: $37.20 billion | Fiscal year 2014: $37.96 billion | Fiscal year 2013: $37.94 billion | Fiscal year 2012: $37.65 billion | Fiscal year 2010: $37.70 billion | Fiscal year 2009: $35.77 billion | Fiscal year 2008: $34.57 billion | Fiscal year 2007: $31.32 billion.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026